In an analysis of NSCLC (non-small cell lung carcinoma) patients, Hsu et al. 40 showed that hypermethylation of the promoter regions of the hMSH2 and hMLH1 genes was associated with poor patient survival. This evidence concerns the gene MLH1 and non-small cell lung carcinoma.